In addition, the release of HMGB1 from dying tumor cells promotes interactions of toll-like receptor 4 (TLR-4), a pattern recognition receptor that signals through the TLR-4-MyD88 axis on DCs, that elicit potent immunostimulatory effects [16]. Here, TLR4 is linked to neoplasm.